Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024Management to host virtual investor event on April 8 to highlight preliminary Phase 1 Data for VIP236, our first-in-class small molecule-drug conjugate (SMDC)
